Author： Demas Penelope A. Thea Donald M. Weedon Jeremy McWayne Janis Bamji Mahrukh Lambert Genevieve Schoenbaum Ellie E.
Publisher： Haworth Press
ISSN： 0363-0242
Source： Women & Health, Vol.42, Iss.1, 2006-12, pp. : 99-115
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Adherence to zidovudine (ZDV) prophylaxis among 78 pregnant HIV-infected women was measured with 2 physiologic markers. Long-term adherence was measured with blood assays for macrocytosis, a clinical indicator of ZDV use; 53 women (67.9%) were adherent. Short-term adherence was measured with urine assays for ZDV; 48 women (61.5%) were adherent. Comparison of urine assay and interview data indicated that 29% had not taken the last dose that they reported. Participation in HIV support groups and disclosure to the participant's mother were associated with better adherence. These social network factors may enable HIV-infected pregnant women to cope more effectively with the multiple stressors they face and facilitate prenatal care.
Related content
Access to resources
Recommend
By Ruiz J.D.
Maternal and Child Health Journal, Vol. 02, Iss. 2, 1998-06 ,pp. :